세계 CGT(세포 및 유전자 치료) 툴 및 시약 시장 규모는 2024년 100억 달러에서 예측 기간 동안 10.8%의 연평균 복합 성장률(CAGR)을 기록하며 2029년에는 167억 달러에 달할 것으로 예상됩니다.
북미 시장은 2024년 46억 달러에서 연평균 12.1% 성장하여 2029년에는 82억 달러에 이를 것으로 예상됩니다. 유럽 시장은 2024년 26억 달러에서 연평균 10.5% 성장하여 2029년에는 43억 달러에 달할 것으로 예상됩니다.
세계 CGT(세포 및 유전자 치료) 툴 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
- 개요
- 기술적 배경 : 세포 치료
- 세포 치료의 유형
- 기술적 배경 : 유전자 치료
- 유전자 치료의 유형
- 승인을 획득한 CGT 제품
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- CGT 연구에 대한 투자
- 임상 및 상업 제조능력 확대
- 만성질환 발생률 증가
- 협업과 인수
- 시장 성장 억제요인
- 제조와 공급망 복잡성
- 숙련된 인재 부족
- 시장 기회
- CGT 기술 진보 활용
- 규제 상황
- 유전자 치료 규제
- 세포 치료 규제
- 바이러스 벡터 및 비바이러스 벡터
- 배지
- GMP 단백질과 항체
- 백혈구 제거 요법
- 유럽 CGT Regulations
제4장 신기술과 개발
제5장 시장 세분화 분석
- 시장 동향
- 세분화 내역
- 세계의 CGT 툴 및 시약 시장 : 제품별
- 면역측정
- 바이오리액터
- 백혈구 제거 요법
- GMP 항체
- 멀티플렉스 면역측정
- 벡터
- 세포 분리
- 동결 보존
- 세포 증식
- 배지
- GMP 단백질
- GMP 소분자
- CRS 모니터링
- 세계의 CGT 툴 및 시약 시장 : 용도별
- 암
- 희귀질환
- 기타 질병
- 세계의 CGT 툴 및 시약 시장 : 최종사용자별
- 제약 기업 및 바이오테크놀러지 기업
- 학술연구기관
- 임상실험실
- 지역별 분석
- 세계의 CGT 툴 및 시약 시장 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
- 주요 기업 순위
- 주요 기업의 전략
- 제품 발매
- 협업 및 파트너십
- 확장
- 합의
- 인수
- 기타
제7장 CGT 툴 및 시약 시장 지속가능성 : ESG 관점
- ESG : 서론
- 업계 ESG 퍼포먼스
- CGT 툴 및 시약 업계에서의 ESG 실천
- 환경 퍼포먼스
- BCC의 결론
제8장 부록
- 조사 방법
- 약어
- 참고 문헌
- 기업 개요
- ABCAM LTD.
- ADVERUM BIOTECHNOLOGIES INC.
- AKRON BIOTECH
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE
- CYTIVA
- FUJIFILM IRVINE SCIENTIFIC
- MILTENYI BIOTEC
- PROTEINTECH GROUP INC.
- QIAGEN
- REVVITY
- SARTORIUS CELLGENIX GMBH
- STEMCELL TECHNOLOGIES
- THERMO FISHER SCIENTIFIC INC.
LSH
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
The North American market for CGT Tools and Reagents is estimated to increase from $4.6 billion in 2024 to reach $8.2 billion by 2029, at a CAGR of 12.1% from 2024 through 2029.
The European market for CGT Tools and Reagents is estimated to increase from $2.6 billion in 2024 to reach $4.3 billion by 2029, at a CAGR of 10.5% from 2024 through 2029.
Report Scope
This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.
Report Includes
- 44 data tables and 57 additional tables
- An update on the global market for cell and gene therapy tools and reagents
- Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
- Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
- Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
- Coverage of the technological, economic and business considerations of the market, and the vendor landscape
- Analysis of the industry's regulatory framework and policies, and product pipeline
- Discussion of ESG challenges and ESG practices in the industry
- Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
- Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Technology Background: Cell Therapy
- Types of Cell Therapy
- Technology Background: Gene Therapy
- Types of Gene Therapy
- Approved CGT Products
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Investments in CGT Research
- Capacity Expansions for Clinical and Commercial Manufacturing
- Increasing Incidence of Chronic Diseases
- Collaborations and Acquisitions
- Market Restraints
- Complexity in Manufacturing and Supply Chain
- Lack of Skilled Force
- Market Opportunities
- Harnessing the Advances in CGT Technologies
- Regulatory Landscape
- Gene Therapy Regulations
- Cell Therapy Regulations
- Viral and Non-Viral Vectors
- Media
- GMP Proteins and Antibodies
- Leukapheresis
- CGT Regulations in Europe
Chapter 4 Emerging Technologies and Developments
- Closed and Automated Systems
- Single-Use Technologies
Chapter 5 Market Segmentation Analysis
- Market Trends
- Segmentation Breakdown
- Global Market for CGT Tools and Reagents, by Product
- Immunoassays
- Bioreactors
- Leukapheresis
- GMP Antibodies
- Multiplex Immunoassays
- Vectors
- Cell Separation
- Cryopreservation
- Cell Expansion
- Media
- GMP Proteins
- GMP Small Molecules
- CRS Monitoring
- Global Market for CGT Tools and Reagents, by Application
- Cancer
- Rare Diseases
- Other Diseases
- Global Market for CGT Tools and Reagents, by End User
- Pharmaceutical and Biotech Companies
- Academic and Research Institutes
- Clinical Laboratories
- Geographic Breakdown
- Global Market for CGT Tools and Reagents, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Ranking of Leading Players
- Strategies of Leading Companies
- Product Launches
- Collaborations and Partnerships
- Expansions
- Agreements
- Acquisitions
- Others
Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective
- Introduction to ESG
- ESG Performance in the Industry
- ESG Practices in the CGT Tool and Reagent Industry
- Environmental Performance
- Concluding Remarks from BCC Research
Chapter 8 Appendix
- Methodology
- Abbreviations
- References
- Company Profiles
- ABCAM LTD.
- ADVERUM BIOTECHNOLOGIES INC.
- AKRON BIOTECH
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE
- CYTIVA
- FUJIFILM IRVINE SCIENTIFIC
- MILTENYI BIOTEC
- PROTEINTECH GROUP INC.
- QIAGEN
- REVVITY
- SARTORIUS CELLGENIX GMBH
- STEMCELL TECHNOLOGIES
- THERMO FISHER SCIENTIFIC INC.
